KP Tissue (TSE:KPT – Get Free Report) released its quarterly earnings results on Thursday. The company reported C$0.22 earnings per share for the quarter, reports.
Here are the key takeaways from KP Tissue’s conference call:
- KP Tissue reported Q1 2026 adjusted EBITDA of CAD 86.9 million, up 14.6% year over year, with margin improving to 16.0% from 13.9% on the back of lower pulp and warehousing costs.
- Revenue was essentially flat at CAD 544.6 million, as modest growth in Canada was offset by a decline in U.S. sales and unfavorable foreign exchange.
- The company said its operations outperformed targets across all sites, and the new Memphis converting line ramped as planned in early Q2 to add capacity to the U.S. network.
- Management reiterated plans for a new western U.S. TAD tissue plant, targeting an official announcement by the end of the first half of 2026 and startup in late 2028.
- Executives flagged rising fuel, freight and other input costs as a key watch item, saying they will consider pricing actions if needed, while Q2 adjusted EBITDA is expected to be in line with Q1.
KP Tissue Price Performance
KPT stock traded up C$0.09 during trading on Thursday, reaching C$11.59. 16,505 shares of the stock traded hands, compared to its average volume of 13,881. The business’s 50 day moving average price is C$11.08 and its 200-day moving average price is C$10.50. KP Tissue has a 52-week low of C$8.50 and a 52-week high of C$11.60. The firm has a market capitalization of C$116.07 million, a PE ratio of 13.64, a P/E/G ratio of -0.88 and a beta of 0.47.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Report on KP Tissue
KP Tissue Company Profile
KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems.
See Also
- Five stocks we like better than KP Tissue
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
